FDA Inspection 1121684 — Skin Care Plus, Ltd. / FXM Research International
The FDA completed an inspection of Skin Care Plus, Ltd. / FXM Research International on February 17, 2020 in Castries. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 17, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Castries (Saint Lucia)
Additional Details
Clinical BA/BE